Committee for Medicinal Products for Human Use (CHMP) Blood Products Working Party (BPWP) stakeholders meeting on normal immunoglobulin for intravenous administration (IVIg) guidance
EventHuman
Date
- Friday, 27 November 2009, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The BPWP is holding a stakeholder meeting, following the public consultation on the note for guidance on the clinical investigation of IVIg and the core summary of product characteristics for IVIg.